Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Joshua N. Liberman"'
Autor:
Joshua N. Liberman, Jacqueline Pesa, Pinyao Rui, Amanda Teeple, Susan Lakey, Emily Wiggins, Brian Ahmedani
Publikováno v:
Psychiatric Research and Clinical Practice, Vol 4, Iss 4, Pp 102-112 (2022)
Objective To develop and validate algorithms to identify individuals with major depressive disorder (MDD) at elevated risk for suicidality or for an acute care event. Methods We conducted a retrospective cohort analysis among adults with MDD diagnose
Externí odkaz:
https://doaj.org/article/313e73c2d7af4bb98a864123cf06b543
Autor:
Joshua N. Liberman, Tigwa Davis, Dawn Velligan, Delbert Robinson, William Carpenter, Chris Jaeger, Heidi Waters, Charles Ruetsch, Felicia Forma
Publikováno v:
Psychiatric Research and Clinical Practice, Vol 4, Iss 2, Pp 61-70 (2022)
Objective To understand perspectives of mental health care providers regarding barriers and drivers of adopting a medication ingestible event monitoring (IEM) system in clinical practice. Methods Between April and October 2019, a cross‐sectional, o
Externí odkaz:
https://doaj.org/article/9a48fe7bd2c64ef29bcb71d4460aa56a
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Individuals with schizophrenia are a vulnerable and under-served population who are also at risk for severe morbidity and mortality following COVID-19 infection. Our research was designed to identify factors that put individuals w
Externí odkaz:
https://doaj.org/article/7c9efde2f0dc4be5823275677ca8f21b
Autor:
Joshua N. Liberman, Sandipan Bhattacharjee, Pinyao Rui, Charles Ruetsch, Brian Rothman, Amit Kulkarni, Felicia Forma
Publikováno v:
Health Services Research & Managerial Epidemiology, Vol 9 (2022)
Objective To estimate the impact COVID-19 pandemic on healthcare resource utilization (HCRU) among individuals with major depressive disorder (MDD). Method A retrospective cohort study was conducted to compare HCRU in the twelve months prior to and s
Externí odkaz:
https://doaj.org/article/278cf1ffd6164ab7b3dd50d057a5f02e
Autor:
Charles Ruetsch, Joshua N. Liberman, Tigwa H. Davis, Martha Sajatovic, Dawn I. Velligan, Emily K. Wiggins, Felicia Forma
Publikováno v:
Journal of Affective Disorders Reports, Vol 9, Iss , Pp 100344- (2022)
Background: Adherence to antipsychotic medications is critical for treatment and relapse prevention in serious mental illness. Accurate assessment of medication adherence can be difficult, clinicians frequently overestimate patient adherence, and new
Externí odkaz:
https://doaj.org/article/cfce40a85bac484481629ba32b801d9a
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 23:327-335
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8cd6528e4f7142aa923d728042bc80c
https://doi.org/10.1080/14737167.2023.2167712
https://doi.org/10.1080/14737167.2023.2167712
Autor:
Charles Ruetsch, Tigwa Davis, Joshua N Liberman, Dawn I Velligan, Delbert Robinson, Chris Jaeger, William Carpenter, Felicia Forma
Publikováno v:
Neuropsychiatric Disease and Treatment
Charles Ruetsch,1 Tigwa Davis,1 Joshua N Liberman,1 Dawn I Velligan,2 Delbert Robinson,3 Chris Jaeger,4 William Carpenter,5 Felica Forma6 1Health Analytics, LLC, Columbia, MD, USA; 2Department of Psychiatry, University of Texas Health Science Center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca2a47c81c8f1267fcbea4237898c79
https://doi.org/10.2147/ndt.s318344
https://doi.org/10.2147/ndt.s318344
Publikováno v:
Neuropsychiatric Disease and Treatment.
Felicia Forma,1 Joshua N Liberman,2 Pinyao Rui,2 Emily Wiggins,2 Charles Ruetsch2 1Health Economics & Real-World Evidence, Formerly Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA; 2Health Analytics, LLC, Columbia, MD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37924a2c1c9ca97ae69b57075348d702
https://www.dovepress.com/measuring-response-to-adjunctive-therapy-among-individuals-with-major--peer-reviewed-fulltext-article-NDT
https://www.dovepress.com/measuring-response-to-adjunctive-therapy-among-individuals-with-major--peer-reviewed-fulltext-article-NDT
Background: Schizophrenia is a serious mental illness and individuals with schizophrenia are a particularly vulnerable and often under-served population. Methods: This research sought to evaluate the factors associated with risk of COVID-19 infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9e2a9a5e3b9cab1fc9990ada1f77bfd
https://doi.org/10.21203/rs.3.rs-1167919/v1
https://doi.org/10.21203/rs.3.rs-1167919/v1
Publikováno v:
PharmacoEconomics - open. 6(6)
Evaluate the cost of illness associated with the 90-day period following acute myocardial infarction (AMI) and the implication of care pathway (percutaneous coronary intervention [PCI] vs medical management [MM]), in order to assess the potential fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea9df3a312537b0717526bb3caf0e00
https://pubmed.ncbi.nlm.nih.gov/36165911
https://pubmed.ncbi.nlm.nih.gov/36165911